L’Oréal Acquires Majority Stake in High-End Skincare Brand Medik8

L’Oréal Groupe is set to acquire a majority stake in the British premium skincare brand Medik8, known for its vitamin A-focused products. The acquisition will place Medik8 within L’Oréal’s Luxe Division, pending regulatory approvals. While financial terms were not disclosed, Medik8’s recent growth and expected global revenues of around US$115 million highlight its market strength. The brand, founded by Elliot Isaacs, will continue under its current management with Isaacs remaining on the board. This move bolsters L’Oréal’s presence in the dermocosmetics sector, aligning Medik8 alongside brands like La Roche-Posay and CeraVe.